Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate Cancer.
Eur Urol Oncol. 2019 Feb;2(1):88-96
Nat Commun. 2019 Jan 17;10(1):382
Prenat Diagn. 2018 Dec 10;:
Nat Commun. 2018 Nov 05;9(1):4616
Correlation of 3T multiparametric prostate MRI using prostate imaging reporting and data system (PIRADS) version 2 with biopsy as reference standard.
Abdom Radiol (NY). 2018 Jul 21;:
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.
Nat Commun. 2018 Jun 11;9(1):2256
J Urol. 2018 May 11;:
Role of MRI-targeted Biopsy in Detection of Prostate Cancer Harbouring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma.
J Urol. 2018 Jan 31;:
Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicion.
Urol Oncol. 2017 Aug 03;:
Modern-day prostate cancer is not meaningfully associated with lower urinary tract symptoms: Analysis of a propensity score-matched cohort.
Can Urol Assoc J. 2017 Jan-Feb;11(1-2):41-46